Adam Chazan

Adam Chazan is a Healthcare Analyst at Pacific Growth Equities. He
previously worked at Merrill Lynch as an Equity Research Analyst
following companies in the life sciences tools, genomics and drug
discovery sectors. Prior to Merrill, he was in the healthcare equity
research group at both ING Barings LLC and William Blair & Company. He
has an MS in Biotechnology from Northwestern University and a BS from
Cornell University.